ARVN
Price
$17.57
Change
-$0.71 (-3.88%)
Updated
Mar 10, 04:59 PM (EDT)
Capitalization
1.21B
56 days until earnings call
CRGX
Price
$4.02
Change
+$0.06 (+1.52%)
Updated
Mar 10, 04:59 PM (EDT)
Capitalization
184.57M
10 days until earnings call
Ad is loading...

ARVN vs CRGX

Header iconARVN vs CRGX Comparison
Open Charts ARVN vs CRGXBanner chart's image
Arvinas
Price$17.57
Change-$0.71 (-3.88%)
Volume$10.55K
Capitalization1.21B
CARGO Therapeutics
Price$4.02
Change+$0.06 (+1.52%)
Volume$4.32K
Capitalization184.57M
ARVN vs CRGX Comparison Chart
Loading...
ARVN
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
CRGX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
ARVN vs. CRGX commentary
Mar 11, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ARVN is a Hold and CRGX is a Buy.

Ad is loading...
COMPARISON
Comparison
Mar 11, 2025
Stock price -- (ARVN: $16.52 vs. CRGX: $3.80)
Brand notoriety: ARVN and CRGX are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: ARVN: 145% vs. CRGX: 50%
Market capitalization -- ARVN: $1.21B vs. CRGX: $184.57M
ARVN [@Biotechnology] is valued at $1.21B. CRGX’s [@Biotechnology] market capitalization is $184.57M. The market cap for tickers in the [@Biotechnology] industry ranges from $355.07B to $0. The average market capitalization across the [@Biotechnology] industry is $2.46B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

ARVN’s FA Score shows that 0 FA rating(s) are green whileCRGX’s FA Score has 1 green FA rating(s).

  • ARVN’s FA Score: 0 green, 5 red.
  • CRGX’s FA Score: 1 green, 4 red.
According to our system of comparison, CRGX is a better buy in the long-term than ARVN.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

ARVN’s TA Score shows that 3 TA indicator(s) are bullish while CRGX’s TA Score has 5 bullish TA indicator(s).

  • ARVN’s TA Score: 3 bullish, 4 bearish.
  • CRGX’s TA Score: 5 bullish, 2 bearish.
According to our system of comparison, CRGX is a better buy in the short-term than ARVN.

Price Growth

ARVN (@Biotechnology) experienced а -6.51% price change this week, while CRGX (@Biotechnology) price change was -2.06% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +0.83%. For the same industry, the average monthly price growth was -7.68%, and the average quarterly price growth was -7.34%.

Reported Earning Dates

ARVN is expected to report earnings on May 06, 2025.

CRGX is expected to report earnings on May 14, 2025.

Industries' Descriptions

@Biotechnology (+0.83% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
ARVN($1.21B) has a higher market cap than CRGX($185M). ARVN YTD gains are higher at: -13.824 vs. CRGX (-73.648). CRGX has higher annual earnings (EBITDA): -147.33M vs. ARVN (-243.6M). ARVN has more cash in the bank: 1.04B vs. CRGX (405M). ARVN has less debt than CRGX: ARVN (9.7M) vs CRGX (28.6M). ARVN has higher revenues than CRGX: ARVN (263M) vs CRGX (0).
ARVNCRGXARVN / CRGX
Capitalization1.21B185M654%
EBITDA-243.6M-147.33M165%
Gain YTD-13.824-73.64819%
P/E RatioN/AN/A-
Revenue263M0-
Total Cash1.04B405M257%
Total Debt9.7M28.6M34%
FUNDAMENTALS RATINGS
ARVN: Fundamental Ratings
ARVN
OUTLOOK RATING
1..100
8
VALUATION
overvalued / fair valued / undervalued
1..100
35
Fair valued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
100
PRICE GROWTH RATING
1..100
88
P/E GROWTH RATING
1..100
100
SEASONALITY SCORE
1..100
n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
ARVNCRGX
RSI
ODDS (%)
N/A
Bullish Trend 7 days ago
90%
Stochastic
ODDS (%)
Bullish Trend 7 days ago
81%
Bullish Trend 7 days ago
90%
Momentum
ODDS (%)
Bearish Trend 7 days ago
83%
Bullish Trend 7 days ago
90%
MACD
ODDS (%)
Bearish Trend 7 days ago
90%
Bullish Trend 7 days ago
90%
TrendWeek
ODDS (%)
Bearish Trend 7 days ago
85%
Bearish Trend 7 days ago
81%
TrendMonth
ODDS (%)
Bearish Trend 7 days ago
85%
Bullish Trend 7 days ago
90%
Advances
ODDS (%)
Bullish Trend 11 days ago
80%
Bullish Trend 15 days ago
89%
Declines
ODDS (%)
Bearish Trend 15 days ago
81%
Bearish Trend 12 days ago
79%
BollingerBands
ODDS (%)
Bullish Trend 7 days ago
83%
N/A
Aroon
ODDS (%)
Bearish Trend 7 days ago
90%
Bearish Trend 7 days ago
90%
View a ticker or compare two or three
Ad is loading...
ARVN
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
CRGX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
CRYPTO / NAMEPrice $Chg $Chg %
BTC.X87222.1950001156.515600
+1.34%
Bitcoin cryptocurrency
GME24.30-0.10
-0.41%
GameStop Corp
AAPL235.93-2.10
-0.88%
Apple
SPY576.86-6.91
-1.18%
SPDR® S&P 500® ETF Trust
TSLA272.04-12.61
-4.43%
Tesla

ARVN and

Correlation & Price change

A.I.dvisor indicates that over the last year, ARVN has been loosely correlated with IPSC. These tickers have moved in lockstep 48% of the time. This A.I.-generated data suggests there is some statistical probability that if ARVN jumps, then IPSC could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ARVN
1D Price
Change %
ARVN100%
+1.79%
IPSC - ARVN
48%
Loosely correlated
-1.43%
CRBU - ARVN
47%
Loosely correlated
+2.80%
IMNM - ARVN
46%
Loosely correlated
+0.45%
AURA - ARVN
46%
Loosely correlated
+4.02%
KYMR - ARVN
44%
Loosely correlated
+1.69%
More

CRGX and

Correlation & Price change

A.I.dvisor indicates that over the last year, CRGX has been loosely correlated with ERAS. These tickers have moved in lockstep 43% of the time. This A.I.-generated data suggests there is some statistical probability that if CRGX jumps, then ERAS could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To CRGX
1D Price
Change %
CRGX100%
+3.26%
ERAS - CRGX
43%
Loosely correlated
+3.13%
ALLO - CRGX
41%
Loosely correlated
+5.56%
CRNX - CRGX
40%
Loosely correlated
-0.23%
IKT - CRGX
39%
Loosely correlated
-3.08%
KYMR - CRGX
39%
Loosely correlated
+1.69%
More